Retraction: SALL4 as an Epithelial-Mesenchymal Transition and Drug Resistance Inducer through the Regulation of c-Myc in Endometrial Cancer

The PLOS ONE Editors

DOI: https://doi.org/10.1371/journal.pone.0298990

IF: 3.7

2024-02-14

PLoS ONE

Abstract:Following publication of this article [1] concerns were raised regarding Figs 1, 2, and 5. Specifically,

multidisciplinary sciences

What problem does this paper attempt to address?

Retraction: Epithelial-Mesenchymal Transition Markers and HER3 Expression Are Predictors of Elisidepsin Treatment Response in Breast and Pancreatic Cancer Cell Lines

The PLOS ONE Editors

DOI: https://doi.org/10.1371/journal.pone.0298557

IF: 3.7

2024-02-06

PLoS ONE

Abstract:After this article [1] was published, concerns were raised about results reported in Figs 2–5.

multidisciplinary sciences
Sall4 is A New Target in Endometrial Cancer

A Li,Y Jiao,K J Yong,F Wang,C Gao,B Yan,S Srivastava,G S D Lim,P Tang,H Yang,D G Tenen,L Chai

DOI: https://doi.org/10.1038/onc.2013.529

IF: 8.756

2013-01-01

Oncogene

Abstract:Aggressive cancers and embryonic stem (ES) cells share a common gene expression signature. Identifying the key factors/pathway(s) within this ES signature responsible for the aggressiveness of cancers can lead to a potential cure. In this study, we find that SALL4, a gene involved in the maintenance of ES cell self-renewal, is aberrantly expressed in 47.7% of primary human endometrial cancer samples. It is not expressed in normal or hyperplastic endometrial. More importantly, SALL4 expression is positively correlated with worse patient survival and aggressive features such as metastasis in endometrial carcinoma. Further functional studies have shown that loss of SALL4 inhibits endometrial cancer cell growth in vitro and tumorigenicity in vivo , as a result of inhibition of cell proliferation and increased apoptosis. In addition, downregulation of SALL4 significantly impedes the migration and invasion properties of endometrial cancer cells in vitro and their metastatic potential in vivo . Furthermore, manipulation of SALL4 expression can affect drug sensitivity of endometrial cancer cells to carboplatin. Moreover, we show that SALL4 specifically binds to the c-Myc promoter region in endometrial cancer cells. While downregulation of SALL4 leads to a decreased expression of c-Myc at both protein and mRNA levels, ectopic SALL4 overexpression causes increased c-Myc protein and mRNA expression, indicating that c-Myc is one of the SALL4 downstream targets in endometrial tumorigenesis. In summary, we are the first to demonstrate that SALL4 has functional role(s) in metastasis and drug resistance in aggressive endometrial cancer. As a consequence of its functional roles in cancer cell and absence in normal tissue, SALL4 is a potential novel therapeutic target for the high-risk endometrial cancer patient population.
Retraction: Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors

The PLOS ONE Editors

DOI: https://doi.org/10.1371/journal.pone.0298013

IF: 3.7

2024-01-26

PLoS ONE

Abstract:Following the publication of this article [1] and the subsequent Expression of Concern [2] further concerns were raised regarding Figures 3 and 4. Specifically:

multidisciplinary sciences
[Retracted] p68 prompts the epithelial‐mesenchymal transition in cervical cancer cells by transcriptionally activating the TGF‐β1 signaling pathway

Ming-Yi Li,Jin-Quan Liu,Dong-Ping Chen,Zhou-Yu Li,Bin Qi,Wen-Jing Yin,Lu He

DOI: https://doi.org/10.3892/ol.2024.14708

2024-10-02

Oncology Letters

Abstract:Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that the scratch‐wound assay data shown in Fig. 2C on p. 2114 were strikingly similar to data that had already appeared in a pair of previously published articles written by different authors at different research institutes. Owing to the fact that the contentious data in the above article had already been published prior to its submission to Oncology Letters , the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Letters 15: 2111-2116, 2018; DOI: 10.3892/ol.2017.7552]

oncology
[Retracted] Activation of the LKB1‐SIK1 signaling pathway inhibits the TGF‐β‐mediated epithelial‐mesenchymal transition and apoptosis resistance of ovarian carcinoma cells

Bo Hong,Jianmei Zhang,Wenlan Yang

DOI: https://doi.org/10.3892/mmr.2024.13180

IF: 3.423

2024-02-10

Molecular Medicine Reports

Abstract:Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the Transwell invasion and migration assay data shown in Figs. 2C and 3F were strikingly similar to data appearing in different form in other articles written by different authors at different research institutes, which had either already been published or were under consideration for publication at around the same time. Owing to the fact that the contentious data in the above article had already been published prior to its submission to Molecular Medicine Reports , the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Molecular Medicine Reports 17: 2837‐2844, 2018; DOI: 10.3892/mmr.2017.8229]

oncology,medicine, research & experimental
RETRACTION: CP-31398 inhibits the progression of cervical cancer through reversing the epithelial mesenchymal transition via the downregulation of PAX2s

DOI: https://doi.org/10.1002/jcp.31353

Abstract:Ling Liu, Tan-Tan Yu, Chen-Chen Ren, Li Yang, Shi-Hong Cui, Xiao-An Zhang, "CP-31398 inhibits the progression of cervical cancer through reversing the epithelial mesenchymal transition via the downregulation of PAX2s," Journal of Cellular Physiology 234, no. 3 (2019): 2929-2942, https://doi.org/10.1002/jcp.27109. The above article, published online on 21 August 2018 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors; the journal Editor-in-Chief, Alexander Hutchison; and Wiley Periodicals LLC. The retraction has been agreed due to concerns related to the data presented in the article. Several flaws and inconsistencies between results presented and experimental methods described were found. Additionally, duplications affecting Figures 5a and 5c, and Figure 8a and 8c have been detected. Accordingly, the conclusions of this article are considered invalid by the editors.
Retraction: LBX2-AS1 promotes ovarian cancer progression by facilitating E2F2 gene expression via Mir-455-5p and Mir-491-5p sponging

DOI: https://doi.org/10.1111/jcmm.18563

Abstract:J. Cao, H. Wang, G. Liu, R. Tang, Y. Ding, P. Xu, H. Wang, J. Miao, X. Gu, and S. Han, 'LBX2-AS1 promotes ovarian cancer progression by facilitating E2F2 gene expression via Mir-455-5p and Mir-491-5p sponging', Journal of Cellular and Molecular Medicine 25, no. 2 (2021): 1178-1189, https://doi.org/10.1111/jcmm.16185. The above article, published online on 20 December 2020 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Stefan Constantinescu; The Foundation for Cellular and Molecular Medicine; and John Wiley and Sons Ltd. The retraction has been agreed following an investigation into concerns raised by a third party, which revealed inappropriate duplications of image panels (Figure 2C, D, E and 5C) between this and other articles that were either previously published or published later in the same year. Thus, the editors consider the conclusions of this manuscript substantially compromised. The authors were informed of the decision to retract but did not respond to the retraction decision or the wording.
IL-6 Secreted by Cancer-Associated Fibroblasts Induces Tamoxifen Resistance in Luminal Breast Cancer

X Sun,Y Mao,J Wang,L Zu,M Hao,G Cheng,Q Qu,D Cui,E T Keller,X Chen,K Shen

DOI: https://doi.org/10.1038/onc.2014.158

IF: 8.756

2014-01-01

Oncogene

Abstract:The authors wish to retract this article due to concerns raised regarding some of the data presented in Figures 2, 4, 5, 6 and Supplementary Figures 6 and 7. According to the data presented in Figures 1, 3 and 7, the major conclusion drawn from this article is still valid: IL-6 secreted by CAFs is causal factor for tamoxifen resistance in luminal breast cancer.
[Retracted] ATP‐binding cassette transporter A7 accelerates epithelial‐to‐mesenchymal transition in ovarian cancer cells by upregulating the transforming growth factor‐β signaling pathway

Xia Liu,Qing Li,Jing Zhou,Su Zhang

DOI: https://doi.org/10.3892/ol.2024.14483

2024-06-05

Oncology Letters

Abstract:Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the wound‐healing assay data shown in Fig. 4C on p. 5872 were strikingly similar to data that had already been published in different form in another article written by different authors at a different research institute [Wang W and Wang J: Toll‐like receptor 4 (TLR4)/cyclooxygenase‐2 (COX‐2) regulates prostate cancer cell proliferation, migration, and invasion by NF‐κB activation. Med Sci Monit 24: 5588‐5597, 2018]. Owing to the fact that the contentious data in the above article had already been published prior to its submission to Oncology Letters , the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Letters 16: 5868‐5874, 2018; DOI: 10.3892/ol.2018.9366]

oncology
Retraction: Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis

The PLOS ONE Editors

DOI: https://doi.org/10.1371/journal.pone.0308113

IF: 3.7

2024-07-26

PLoS ONE

Abstract:Following the publication of this article [1], concerns were raised that the Fig 5D ADV-GFP panel partially overlaps with the Fig 5D PBS panel and the Fig 5D ADV-AsTim-3 panel. A Correction [2] which replaced the Fig 5D ADV-GFP panel was previously issued. However, this Correction [2] did not resolve the concern that the Fig 5D PBS panel and the Fig 5D ADV-AsTim-3 also appear to be part of the same transwell invasion assay membrane, despite these panels being used to represent different experimental conditions.

multidisciplinary sciences
Retracted: CircEIF4G2 Promotes Tumorigenesis and Progression of Osteosarcoma by Sponging miR-218

BioMed Research International

DOI: https://doi.org/10.1155/2024/9758625

2024-03-21

BioMed Research International

Abstract:This article has been retracted by Hindawi following an investigation undertaken by the publisher [1]. This investigation has uncovered evidence of one or more of the following indicators of systematic manipulation of the publication process: (1) Discrepancies in scope (2) Discrepancies in the description of the research reported (3) Discrepancies between the availability of data and the research described (4) Inappropriate citations (5) Incoherent, meaningless and/or irrelevant content included in the article (6) Manipulated or compromised peer review

biotechnology & applied microbiology,medicine, research & experimental
Retraction: Somatostatin Derivative (smsDX) Targets Cellular Metabolism in Prostate Cancer Cells after Androgen Deprivation Therapy

,The PLOS ONE Editors

DOI: https://doi.org/10.1371/journal.pone.0299822

IF: 3.7

2024-02-27

PLoS ONE

Abstract:Following the publication of this article [1], concerns were raised regarding results presented in Fig 2. Specifically,

multidisciplinary sciences
Retraction: Upregulation of HYAL1 Expression in Breast Cancer Promoted Tumor Cell Proliferation, Migration, Invasion and Angiogenesis

The PLOS ONE Editors

DOI: https://doi.org/10.1371/journal.pone.0277500

IF: 3.7

2022-11-08

PLoS ONE

Abstract:After this article [1] was published, concerns were raised about the mouse tumor sizes reported in Fig 7. Specifically, the chart in Fig 7A of the article appears to report tumor sizes of up to 3500 mm 3 .

multidisciplinary sciences
[Retracted] miR‐148a‐3p suppresses epithelial ovarian cancer progression primarily by targeting c‐Met

Wen Wang,Jing Dong,Maoxiu Wang,Shujuan Yao,Xiangyu Tian,Xiujuan Cui,Shijie Fu,Shiqian Zhang

DOI: https://doi.org/10.3892/ol.2024.14644

2024-08-30

Oncology Letters

Abstract:Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that the invasion assay data shown in Fig. 2C on p. 6134 had already appeared in an article written by different authors that had already been submitted for publication [Li P, Wang H, Hou M, Li D and Bai H: Upstream stimulating factor 1 (USF1) enhances the proliferation of glioblastoma stem cells mainly by activating the transcription of mucin 13 (MUC13). Pharmazie 72: 98-102, 2017]. Owing to the fact that the contentious data in the above article had already been submitted for publication prior to its submission to Oncology Letters , the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Letters 15: 6131-6136, 2018; DOI: 10.3892/ol.2018.8110]

oncology
Retracted: SPOCK2 Promotes the Malignant Behavior of Ovarian Cancer via Regulation of the Wnt/β-Catenin Signaling Pathway

BioMed Research International

DOI: https://doi.org/10.1155/2024/9861317

2024-01-09

BioMed Research International

Abstract:[This retracts the article DOI: 10.1155/2022/9223954.].

biotechnology & applied microbiology,medicine, research & experimental
Retraction: Chinese Herbal Medicine Suppresses Invasion-Promoting Capacity of Cancer-Associated Fibroblasts in Pancreatic Cancer

The PLOS ONE Editors

DOI: https://doi.org/10.1371/journal.pone.0313436

IF: 3.7

2024-11-02

PLoS ONE

Abstract:After this article [1] was published, concerns were raised about results presented in Figs 2, 5, and S2. Specifically:

multidisciplinary sciences
[Retracted] MicroRNA‐362 is downregulated in cervical cancer and inhibits cell proliferation, migration and invasion by directly targeting SIX1

Can Shi,Zhenyu Zhang

DOI: https://doi.org/10.3892/or.2024.8713

2024-02-08

Oncology Reports

Abstract:Following the publication of the above article, a concerned reader drew to the Editor's attention that the Transwell cell migration and invasion assay data featured in Fig. 2C were strikingly similar to data appearing in different form in other articles written by different authors at different research institutes that had either already been published elsewhere prior to the submission of this paper to Oncology Reports , or were under consideration for publication at around the same time (some of which have been retracted). Furthermore, a number of overlapping data panels were identified comparing the migration and invasion assay data in Figs. 5C and 6C, such that data which were intended to show the results from differently performed experiments appeared to have been derived from the same original source(s). In view of the fact that certain of these data had already apparently been published previously, and given the lack of rigour on the part of the authors in assembling the data in Figs. 5 and 6, the Editor of Oncology Reports has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a satisfactory reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 37: 501‐509, 2017; DOI: 10.3892/or.2016.5242]

oncology
Retraction: circRASSF2 promotes IGF1R and osteosarcoma metastasis via sponging miR-6838-5p

Fengyan Wang,Hong Sun,Ke Li,Kun Yang,Yang Xiang,Xiaobin Tian

DOI: https://doi.org/10.21037/atm-2024-02

2024-06-10

Abstract:[This retracts the article DOI: 10.21037/atm-21-6123.].
Retraction: Exosomal miR-128-3p promotes epithelial-to-mesenchymal transition in colorectal cancer cells by targeting FOXO4 via TGF-β/SMAD and JAK/STAT3 signaling

Frontiers Editorial Office

DOI: https://doi.org/10.3389/fcell.2024.1459522

IF: 5.5

2024-07-20

Frontiers in Cell and Developmental Biology

Abstract:This article is a retraction of: RETRACTED: Exosomal miR-128-3p Promotes Epithelial-to-Mesenchymal Transition in Colorectal Cancer Cells by Targeting FOXO4 via TGF-β/SMAD and JAK/STAT3 Signaling

cell biology,developmental biology
[Retracted] MEG3/miR‐21 axis affects cell mobility by suppressing epithelial‐mesenchymal transition in gastric cancer

Gang Xu,Lei Meng,Dawei Yuan,Kang Li,Yong Zhang,Chengxue Dang,Kun Zhu

DOI: https://doi.org/10.3892/or.2024.8799

2024-08-20

Oncology Reports

Abstract:Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the Transwell cell invasion assay data shown in Fig. 2B on p. 42 and the immunofluorescence data shown in Fig. 4D on p. 44 were strikingly similar to data appearing in other articles written by different authors at different research institutes that were submitted to different journals at around the same time. Moreover, a further investigation of this paper undertaken by the Editorial Office identified a large number of overlapping data panels comparing the Transwell cell migration and invasion assay data and the scratch‐wound assay data both within and between Figs. 2 and 3, where data which were intended to have shown the results from differently performed experiments had apparently been derived from the same original source, including an overlapping section of data within the 'MEG3+mimic' panel in Fig. 3G that would be difficult to attribute to pure chance. Owing to the fact that the contentious data in the above article had already been submitted for publication at around the same time as its submission to Oncology Reports , and given an overall lack of confidence in the presented data, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 40: 39‐48, 2018; DOI: 10.3892/or.2018.6424]

oncology

Retraction: SALL4 as an Epithelial-Mesenchymal Transition and Drug Resistance Inducer through the Regulation of c-Myc in Endometrial Cancer

Retraction: Epithelial-Mesenchymal Transition Markers and HER3 Expression Are Predictors of Elisidepsin Treatment Response in Breast and Pancreatic Cancer Cell Lines

Sall4 is A New Target in Endometrial Cancer

Retraction: Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors

[Retracted] p68 prompts the epithelial‐mesenchymal transition in cervical cancer cells by transcriptionally activating the TGF‐β1 signaling pathway

[Retracted] Activation of the LKB1‐SIK1 signaling pathway inhibits the TGF‐β‐mediated epithelial‐mesenchymal transition and apoptosis resistance of ovarian carcinoma cells

RETRACTION: CP-31398 inhibits the progression of cervical cancer through reversing the epithelial mesenchymal transition via the downregulation of PAX2s

Retraction: LBX2-AS1 promotes ovarian cancer progression by facilitating E2F2 gene expression via Mir-455-5p and Mir-491-5p sponging

IL-6 Secreted by Cancer-Associated Fibroblasts Induces Tamoxifen Resistance in Luminal Breast Cancer

[Retracted] ATP‐binding cassette transporter A7 accelerates epithelial‐to‐mesenchymal transition in ovarian cancer cells by upregulating the transforming growth factor‐β signaling pathway

Retraction: Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis

Retracted: CircEIF4G2 Promotes Tumorigenesis and Progression of Osteosarcoma by Sponging miR-218

Retraction: Somatostatin Derivative (smsDX) Targets Cellular Metabolism in Prostate Cancer Cells after Androgen Deprivation Therapy

Retraction: Upregulation of HYAL1 Expression in Breast Cancer Promoted Tumor Cell Proliferation, Migration, Invasion and Angiogenesis

[Retracted] miR‐148a‐3p suppresses epithelial ovarian cancer progression primarily by targeting c‐Met

Retracted: SPOCK2 Promotes the Malignant Behavior of Ovarian Cancer via Regulation of the Wnt/β-Catenin Signaling Pathway

Retraction: Chinese Herbal Medicine Suppresses Invasion-Promoting Capacity of Cancer-Associated Fibroblasts in Pancreatic Cancer

[Retracted] MicroRNA‐362 is downregulated in cervical cancer and inhibits cell proliferation, migration and invasion by directly targeting SIX1

Retraction: circRASSF2 promotes IGF1R and osteosarcoma metastasis via sponging miR-6838-5p

Retraction: Exosomal miR-128-3p promotes epithelial-to-mesenchymal transition in colorectal cancer cells by targeting FOXO4 via TGF-β/SMAD and JAK/STAT3 signaling

[Retracted] MEG3/miR‐21 axis affects cell mobility by suppressing epithelial‐mesenchymal transition in gastric cancer